Bellerophon Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
LINDE NORTH AMERICA, INC. 10 percent owner
 Common Stock 1,721,992 N/A N/A
Purchase
LUEHRING JENS director
 Common Stock 10,000 $1.24 $12,420
Purchase
LUEHRING JENS director
 Common Stock 20,000 $0.56 $11,200
Purchase
LINDE NORTH AMERICA, INC. 10 percent owner
 Common Stock Warrants (right to buy) 1,920,000 $0.8 $1,536,000
Purchase
TENENBAUM FABIAN director, officer: Chief Execut..
 Common Stock 142,857 $0.8 $114,286
Purchase
PEACOCK JONATHAN M director
 Common Stock Warrants (right to buy) 285,715 $0.8 $228,572
Purchase
AMIN NASEEM director
 Common Stock Warrants (right to buy) 714,285 $0.8 $571,428
Purchase
PEACOCK JONATHAN M director
 Common Stock 285,715 $0.8 $228,572
Purchase
AMIN NASEEM director
 Common Stock 714,285 $0.8 $571,428
Purchase
LINDE NORTH AMERICA, INC. 10 percent owner
 Common Stock 1,920,000 $0.8 $1,536,000
Purchase
PEACOCK JONATHAN M director
 Common Stock 5,000 $1.37 $6,840
Purchase
PEACOCK JONATHAN M director
 Common Stock 12,800 $2.76 $35,341
Purchase
PEACOCK JONATHAN M director
 Common Stock 7,500 $2.72 $20,400
Purchase
PEACOCK JONATHAN M director
 Common Stock 5,000 $5.48 $27,375
Purchase
MEGLASSON MARTIN officer: Chief Scientific Officer
 Common Stock 712 $8.4 $5,981
Purchase
PEACOCK JONATHAN M director
 Common Stock 5,560 $8.69 $48,322
Purchase
WEINSTEIN ADAM director, 10 percent owner
 Common Stock 1,070,166 $12 $12,841,992
Purchase
HOLT MATTHEW S. director, 10 percent owner
 Common Stock 1,070,166 $12 $12,841,992
Purchase
NELSEN ROBERT director, 10 percent owner
 Common Stock 212,666 $12 $2,551,992
Purchase
MEGLASSON MARTIN officer: Chief Scientific Officer
 Common Stock 12,000 $12 $144,000
Purchase
HEYRMAN REINILDE officer: Chief Clinical Dev. Of..
 Common Stock 1,500 $12 $18,000
Purchase
NAIDU MANESH officer: Chief Business Officer
 Common Stock 1,500 $12 $18,000
Purchase
PEACOCK JONATHAN M director
 Common Stock 20,800 $12 $249,600
Purchase
TASSE DANIEL director
 Common Stock 25,000 $12 $300,000
Purchase
LUEHRING JENS director
 Common Stock 358,916 $12 $4,306,992
Purchase
ARCH VENTURE FUND VI LP 10 percent owner
 Common Stock 212,666 $12 $2,551,992
Purchase
NEW MOUNTAIN INVESTMENTS II, LLC 10 percent owner
 Common Stock 1,070,166 $12 $12,841,992
Purchase
LINDE NORTH AMERICA, INC. 10 percent owner
 Common Stock 358,916 $12 $4,306,992

Showing 50 to 78 of 78 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: